Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Repligen Corporation - Common Stock (NQ:RGEN)

148.67 +3.43 (+2.36%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 772,588
Open 145.69
Bid (Size) 122.95 (1)
Ask (Size) 158.00 (1)
Prev. Close 145.24
Today's Range 145.01 - 150.40
52wk Range 102.97 - 182.52
Shares Outstanding 55,679,964
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Myriad Genetics, Omnicell, Globus Medical, Repligen, and Teleflex Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. 
Via StockStory
Topics Economy Government World Trade
Thermo Fisher Scientific Soars on Strategic Wins, Market Optimism
Thermo Fisher Scientific Inc. (NYSE: TMO) experienced a robust surge in its stock value today, October 1, 2025, climbing an impressive 9.79% as market optimism swelled around a series of recent... 
Via MarketMinute
Topics Artificial Intelligence Economy Government

Performance

YTD
+3.9%
+3.9%
1 Month
+30.9%
+30.9%
3 Month
+22.5%
+22.5%
6 Month
+16.8%
+16.8%
1 Year
+3.9%
+3.9%

More News

Read More
What 8 Analyst Ratings Have To Say About Repligen
Via Benzinga
Analyst Expectations For Repligen's Future
Via Benzinga
Why Is Repligen (RGEN) Stock Soaring Today
Via StockStory
Topics Government
Repligen, BrightSpring Health Services, Danaher, Thermo Fisher, and Amgen Shares Skyrocket, What You Need To Know
Via StockStory
Topics Government
1 Volatile Stock to Target This Week and 2 Facing Challenges
Via StockStory
3 Reasons to Sell RGEN and 1 Stock to Buy Instead
Via StockStory
Topics Stocks
Drug Development Inputs & Services Stocks Q2 Results: Benchmarking Repligen (NASDAQ:RGEN)
Via StockStory
This Sarepta Therapeutics Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Via Benzinga
Small-Cap and Value Stocks Stage a Powerful Comeback: A Market Rebalancing Act Underway
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
Repligen (RGEN) Stock Is Up, What You Need To Know
Via StockStory
Anchored at 4%: Why the Steady 10-Year Treasury Yield is Key to Unlocking the Fed's Stimulus Power
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
1 Cash-Producing Stock with Exciting Potential and 2 We Avoid
Via StockStory
Why Repligen (RGEN) Stock Is Down Today
Via StockStory
Topics Artificial Intelligence Economy
Bond Yields Tumble as Investors Brace for Aggressive Fed Rate Cuts
Via MarketMinute
Topics Bonds Economy Supply Chain
3 Cash-Heavy Stocks We Find Risky
Via StockStory
Repligen, Revvity, Avantor, Fortrea, and Azenta Shares Skyrocket, What You Need To Know
Via StockStory
Topics Economy
3 of Wall Street’s Favorite Stocks with Warning Signs
Via StockStory
3 Unprofitable Stocks We Steer Clear Of
Via StockStory
3 Cash-Producing Stocks We Think Twice About
Via StockStory
NeoGenomics, Progyny, Repligen, Revvity, and Waters Corporation Shares Are Soaring, What You Need To Know
Via StockStory
Topics Economy
AMN Healthcare Services, NeoGenomics, Acadia Healthcare, BrightSpring Health Services, and Repligen Shares Are Soaring, What You Need To Know
Via StockStory
Topics Bonds Economy Stocks
RGEN Q2 Deep Dive: Chromatography and Filtration Drive Growth, Guidance Lifted Amid New Modalities Uncertainty
Via StockStory
1 Safe-and-Steady Stock on Our Buy List and 2 We Turn Down
Via StockStory

Frequently Asked Questions

Is Repligen Corporation - Common Stock publicly traded?
Yes, Repligen Corporation - Common Stock is publicly traded.
What exchange does Repligen Corporation - Common Stock trade on?
Repligen Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Repligen Corporation - Common Stock?
The ticker symbol for Repligen Corporation - Common Stock is RGEN on the Nasdaq Stock Market
What is the current price of Repligen Corporation - Common Stock?
The current price of Repligen Corporation - Common Stock is 148.67
When was Repligen Corporation - Common Stock last traded?
The last trade of Repligen Corporation - Common Stock was at 10/13/25 04:00 PM ET
What is the market capitalization of Repligen Corporation - Common Stock?
The market capitalization of Repligen Corporation - Common Stock is 8.28B
How many shares of Repligen Corporation - Common Stock are outstanding?
Repligen Corporation - Common Stock has 8B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.